Summary
Machine-generated summaryGerman statutory health insurance funds are seeking rebate contracts under Section 130c(1) SGB V for the active substance combination Dolutegravir/Rilpivirin. The procedure is an Open-House original arrangement: no individual negotiations take place, uniform conditions apply to all participants, and no exclusivity is granted. Contracts run for a maximum of 24 months starting on 1 June 2026 and end at the latest on 31 May 2028, regardless of the signing date. If the patent or market exclusivity expires earlier, the contract ends automatically at the end of that month. Pharmaceutical companies can join at any time during the contract term. Further details are in the participation and contract documents.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile52 open tenders right now
- Medicines - Open-House discount contracts 2026-06 - Safinamide 215 days left
- Medicines - Open-House Biosimilar Discount Agreements 2026-03a - Eculizumab (excluding the gMG and NMOSD indications) 338 days left
- Medicines - Open-House Biosimilar Discount Agreements 2026-03b - Eculizumab (including the indications gMG and NMOSD) 338 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 42 | €17.4M | Sep 2026 |
| Philips GmbH | 20 | €5.3M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Sep 2026 |
| ASTRAZENECA GMBH | 12 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 10 | €4.0M | Sep 2026 |
Based on 1018 awards with a linked company profile over the last 2 years.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Submission deadline: Moved 1 day EARLIER: now May 31, 2028, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,072,234
- Buyer track record on Aperlena
- 55 notices tracked · 0 awarded
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert